187 related articles for article (PubMed ID: 36416912)
1. [Multimodal treatment concepts of local radiation therapy with immunotherapy : Rationale for combination therapy and possible clinical treatment strategies].
Eckert F
Urologie; 2022 Dec; 61(12):1324-1331. PubMed ID: 36416912
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Lee L; Matulonis U
Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation and stereotactic radiation: improving local and abscopal responses.
Zeng J; Harris TJ; Lim M; Drake CG; Tran PT
Biomed Res Int; 2013; 2013():658126. PubMed ID: 24324970
[TBL] [Abstract][Full Text] [Related]
4. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
[TBL] [Abstract][Full Text] [Related]
5. Integration of radiotherapy and immunotherapy for treatment of oligometastases.
Pitroda SP; Chmura SJ; Weichselbaum RR
Lancet Oncol; 2019 Aug; 20(8):e434-e442. PubMed ID: 31364595
[TBL] [Abstract][Full Text] [Related]
6. Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play.
Donlon NE; Power R; Hayes C; Davern M; Reynolds JV; Lysaght J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499003
[TBL] [Abstract][Full Text] [Related]
7. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
Tubin S; Popper HH; Brcic L
Radiat Oncol; 2019 Jan; 14(1):21. PubMed ID: 30696472
[TBL] [Abstract][Full Text] [Related]
8. Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy.
D'Andrea MA; Reddy GK
Am J Clin Oncol; 2020 Mar; 43(3):218-228. PubMed ID: 31842114
[TBL] [Abstract][Full Text] [Related]
9. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma.
Yeo ELL; Li YQ; Soo KC; Wee JTS; Chua MLK
Chin Clin Oncol; 2018 Apr; 7(2):15. PubMed ID: 29764160
[TBL] [Abstract][Full Text] [Related]
11. Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes-"Immunological Dose Painting".
Mireştean CC; Crişan A; Buzea C; Iancu RI; Iancu DT
Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33374739
[TBL] [Abstract][Full Text] [Related]
12. The mutual relationship between the host immune system and radiotherapy: stimulating the action of immune cells by irradiation.
Watanabe T; Sato GE; Yoshimura M; Suzuki M; Mizowaki T
Int J Clin Oncol; 2023 Feb; 28(2):201-208. PubMed ID: 35556190
[TBL] [Abstract][Full Text] [Related]
13. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.
Ji D; Song C; Li Y; Xia J; Wu Y; Jia J; Cui X; Yu S; Gu J
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106387
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy and radiotherapy for metastatic cancers.
Bang A; Schoenfeld JD
Ann Palliat Med; 2019 Jul; 8(3):312-325. PubMed ID: 30180743
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy and Radiation Therapy in Renal Cell Carcinoma.
Mollica V; Santoni M; Di Nunno V; Cimadamore A; Cheng L; Lopez-Beltran A; Battelli N; Montironi R; Massari F
Curr Drug Targets; 2020; 21(14):1463-1475. PubMed ID: 32160846
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy combined with immunotherapy: the dawn of cancer treatment.
Zhang Z; Liu X; Chen D; Yu J
Signal Transduct Target Ther; 2022 Jul; 7(1):258. PubMed ID: 35906199
[TBL] [Abstract][Full Text] [Related]
17. The Abscopal Effect: Could a Phenomenon Described Decades Ago Become Key to Enhancing the Response to Immune Therapies in Breast Cancer?
Kolberg HC; Hoffmann O; Baumann R
Breast Care (Basel); 2020 Oct; 15(5):443-449. PubMed ID: 33223988
[TBL] [Abstract][Full Text] [Related]
18. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
Front Immunol; 2019; 10():407. PubMed ID: 30930892
[TBL] [Abstract][Full Text] [Related]
19. Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
Caetano MS; Younes AI; Barsoumian HB; Quigley M; Menon H; Gao C; Spires T; Reilly TP; Cadena AP; Cushman TR; Schoenhals JE; Li A; Nguyen QN; Cortez MA; Welsh JW
Clin Cancer Res; 2019 Dec; 25(24):7576-7584. PubMed ID: 31540976
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
